CompletedPhase 2/3

The Effect of Terazosin and Tolterodine on Ureteral Stent Related Symptoms

Iran104 participantsStarted 2012-01

Plain-language summary

The aim of the investigators study is to evaluate whether alpha-blockers such as terazosin and anti-cholinergics such as tolterodine can be relieve the DJ-stent related symptoms.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Prior history of pelvic surgery
✕. Prior history of Transurethral Resection of the either Prostate or Bladder Tumor
✕. Benign prostate hyperplasia
✕. Recent or recurrent urinary tract infection
✕. Chronic medication with beta-blockers or Anti-cholinergic
✕. Pregnancy
✕. Prostatitis
✕. Prostate cancer

What they're measuring

Lower Urinary Tract Symptoms (LUTS)

Timeframe: Expected average of 2 weeks

Trial details

NCT IDNCT01530243

SponsorUrmia University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-08

Results submitted2015-01-21

View on ClinicalTrials.gov More Disorder of Urinary Stent trials